These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38212795)
61. Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway. Zhang C; Peng Q; Tang Y; Wang C; Wang S; Yu D; Hou S; Wang Y; Zhang L; Lin N J Cancer Res Clin Oncol; 2024 Mar; 150(3):168. PubMed ID: 38546908 [TBL] [Abstract][Full Text] [Related]
62. Effect of Deletion of ANGPTL4 Gene on Viability, Migration and Invasion Ability and Apoptosis of Hepatocellular Carcinoma Cells. Bai Y; Cui G; Sun X; Wei M; Liu Y; Guo J; Yang Y Discov Med; 2024 Jan; 36(180):173-181. PubMed ID: 38273757 [TBL] [Abstract][Full Text] [Related]
63. Integrated transcriptomic and proteomic analysis reveals Guizhi-Fuling Wan inhibiting STAT3-EMT in ovarian cancer progression. Ma Q; Chen F; Liu Y; Wu K; Bu Z; Qiu C; Neamati N; Lu T Biomed Pharmacother; 2024 Jan; 170():116016. PubMed ID: 38128180 [TBL] [Abstract][Full Text] [Related]
64. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434 [TBL] [Abstract][Full Text] [Related]
65. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway. Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871 [TBL] [Abstract][Full Text] [Related]
66. A transcription factor that promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of ovarian cancer cells and its possible mechanisms. Qi Y; Mo K; Zhang T Biomed Eng Online; 2021 Aug; 20(1):83. PubMed ID: 34399777 [TBL] [Abstract][Full Text] [Related]
67. Suppression of angiopoietin-like 4 reprograms endothelial cell metabolism and inhibits angiogenesis. Chaube B; Citrin KM; Sahraei M; Singh AK; de Urturi DS; Ding W; Pierce RW; Raaisa R; Cardone R; Kibbey R; Fernández-Hernando C; Suárez Y Nat Commun; 2023 Dec; 14(1):8251. PubMed ID: 38086791 [TBL] [Abstract][Full Text] [Related]
68. Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer. Liu JF; Deng WW; Chen L; Li YC; Wu L; Ma SR; Zhang WF; Bu LL; Sun ZJ Mol Carcinog; 2018 Mar; 57(3):429-439. PubMed ID: 29215754 [TBL] [Abstract][Full Text] [Related]
69. Hsa_circ_0013561 promotes progression of nasopharyngeal carcinoma by activating JAK2/STAT3 signaling pathway. Kaisai T; Mantang Z; Tailei Y; Liying Z; Xiaoping C; Mingming J; Yi Z Braz J Otorhinolaryngol; 2024; 90(1):101362. PubMed ID: 38006726 [TBL] [Abstract][Full Text] [Related]
70. Potential role of ANGPTL4 in cancer progression, metastasis, and metabolism: a brief review. Park MS; Kim SE; Lee P; Lee JH; Jung KH; Hong SS BMB Rep; 2024 Aug; 57(8):343-351. PubMed ID: 39044455 [TBL] [Abstract][Full Text] [Related]
71. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta. Jin A; Zhang L; Fang G; Chen Y Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590 [TBL] [Abstract][Full Text] [Related]
72. Angiopoietin-like 4 stimulates STAT3-mediated iNOS expression and enhances angiogenesis to accelerate wound healing in diabetic mice. Chong HC; Chan JS; Goh CQ; Gounko NV; Luo B; Wang X; Foo S; Wong MT; Choong C; Kersten S; Tan NS Mol Ther; 2014 Sep; 22(9):1593-604. PubMed ID: 24903577 [TBL] [Abstract][Full Text] [Related]
73. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma. Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864 [TBL] [Abstract][Full Text] [Related]
74. Circ_0070203 Promotes Epithelial-mesenchymal Transition in Ovarian Serous Cystadenocarcinoma through miR-370-3p/TGFβR2 Axis. Tang Q; Wen H; Hu H; Chen X; Xu S; Fan L; Liu L; Li J Recent Pat Anticancer Drug Discov; 2024; 19(2):233-246. PubMed ID: 38214360 [TBL] [Abstract][Full Text] [Related]
75. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375. Li L; Xiao C; He K; Xiang G IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288 [TBL] [Abstract][Full Text] [Related]
76. ANGPTL4: a multifunctional protein involved in metabolism and vascular homeostasis. Fernández-Hernando C; Suárez Y Curr Opin Hematol; 2020 May; 27(3):206-213. PubMed ID: 32205586 [TBL] [Abstract][Full Text] [Related]
77. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma. Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144 [TBL] [Abstract][Full Text] [Related]
78. Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis. Wu Z; Jiao M; Shu C; Zhang S; Wang J; Pu J; Zhu J; Zeng Y; Zhu Y; Liu Z Cell Commun Signal; 2024 Jun; 22(1):313. PubMed ID: 38844957 [TBL] [Abstract][Full Text] [Related]
79. Long non-coding RNA HAL suppresses the migration and invasion of serous ovarian cancer by inhibiting EMT signaling pathway. Wu K; Li L; Li L; Wang D Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039453 [TBL] [Abstract][Full Text] [Related]
80. Tumor-suppressive role of miR-139-5p in angiogenesis and tumorigenesis of ovarian cancer: Based on GEO microarray analysis and experimental validation. Tan S; Chen X; Liu W Cell Signal; 2023 Sep; 109():110730. PubMed ID: 37244634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]